Restylane Lyft with Lidocaine
FDA premarket approval P040024/S109 · decided 2019-11-04
Approval details
- PMA number
- P040024
- Supplement
- S109
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- Restylane Lyft with Lidocaine
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Q-Med AB
- Date received
- 2019-04-01
- Decision date
- 2019-11-04
- Days to decision
- 217 days
- Decision code
- APPR
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Uppsala
- Statement
- Approval for revisions to the active thumb flexion information and post marketing surveillance data in your clinician and patient labeling.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.